1. What is the decision or change (e.g. clinical topic, practice guideline, system design, delivery of care) you are facing or struggling with where a summary of the evidence would be helpful?

Questions: What are the relative effectiveness and risks to preventing hemorhragic stroke in those with prior Afib episodes by: 1. ) inserting a transcatheter LAA and to enable discontinuation of anticoagulants (ex.: apixaban) - but not a.s.a; or 2) avoiding the LAA procedure and continuing the anticoaguolant?

2. Why are you struggling with this issue?

Find no comparison data regarding effect on longevity.

3. What do you want to see changed? How will you know that your issue is improving or has been addressed?

Guidance re decision making for treatment with the LAA

4. What will you do with the evidence report?

Aid decision re having the LAA procedure.

Optional Information About You

What is your role or perspective? Patient/consumer

May we contact you if we have questions about your nomination? Yes